Effect of a Fatty Meal on Endoscopic Retrograde Cholangiopancreatography (ERCP)
Effect of a Fatty Meal on Cannulation at Endoscopic Retrograde Cholangiopancreatography
1 other identifier
interventional
80
1 country
1
Brief Summary
This study is to determine if a fatty meal would improve the ERCP procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started May 2003
Longer than P75 for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2004
CompletedFirst Submitted
Initial submission to the registry
July 25, 2005
CompletedFirst Posted
Study publicly available on registry
July 27, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2007
CompletedJuly 31, 2013
July 1, 2013
1.6 years
July 25, 2005
July 29, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
a fatty meal in the study group and normal saline in control group
the procedure time for ERCP
Secondary Outcomes (1)
follow up within 3 days for complication with relation to the cannulation time
within 3 days
Study Arms (1)
a fatty meal vs normal saline
PLACEBO COMPARATORApproximately one hour before ERCP procedure, patient will have a fatty meal in the study group and normal saline in control group
Interventions
Approximately one hour before ERCP procedure, patient will have a fatty meal in the study group and normal saline in control group
Eligibility Criteria
You may qualify if:
- Patients, 18 years and older, who are scheduled for ERCP at Emory University Hospital and signed consent before the procedure.
You may not qualify if:
- Patients with a known allergy to milk or those who choose not to sign the consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Emory Universitylead
Study Sites (1)
Emory University School of Medicine; Emory University Hospital
Atlanta, Georgia, 30322, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Qiang Cai, MD, PhD
Emory University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
July 25, 2005
First Posted
July 27, 2005
Study Start
May 1, 2003
Primary Completion
December 1, 2004
Study Completion
May 1, 2007
Last Updated
July 31, 2013
Record last verified: 2013-07